BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19714522)

  • 1. Are survival rates for Tyrol published in the Eurocare studies biased?
    Oberaigner W; Siebert U
    Acta Oncol; 2009; 48(7):984-91. PubMed ID: 19714522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
    Engholm G; Gislum M; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.
    Parkin DM; Bray F
    Eur J Cancer; 2009 Mar; 45(5):756-64. PubMed ID: 19128954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.
    Nennecke AL; Hentschel S; Reintjes R
    Acta Oncol; 2009; 48(1):34-43. PubMed ID: 18607873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality.
    Bartsch G; Horninger W; Klocker H; Pelzer A; Bektic J; Oberaigner W; Schennach H; Schäfer G; Frauscher F; Boniol M; Severi G; Robertson C; Boyle P;
    BJU Int; 2008 Apr; 101(7):809-16. PubMed ID: 18321314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of department volume on cancer survival for gynaecological cancers--a population-based study in Tyrol, Austria.
    Oberaigner W; Stühlinger W
    Gynecol Oncol; 2006 Nov; 103(2):527-34. PubMed ID: 16730055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy.
    Viscomi S; Pastore G; Mosso ML; Terracini B; Madon E; Magnani C; Merletti F;
    Haematologica; 2003 Sep; 88(9):974-82. PubMed ID: 12969805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The risk of cancer in the Netherlands].
    Kiemeney LA; Lemmers FA; Verhoeven RH; Aben KK; Honing C; de Nooijer J; Peeters PH; Visser O; Vlems FA
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2233-41. PubMed ID: 19009811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coincidence of bladder and prostate cancer.
    Chun TY
    J Urol; 1997 Jan; 157(1):65-7. PubMed ID: 8976217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive epidemiology of cancer in Japan: current cancer incidence and survival data.
    Fujimoto I; Hanai A; Oshima A
    Natl Cancer Inst Monogr; 1979 Nov; (53):5-15. PubMed ID: 537630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment.
    Brenner H; Hakulinen T
    Eur J Cancer; 2005 Aug; 41(12):1788-93. PubMed ID: 16043349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lorraine childhood cancer registry: incidence, survival 1983-1999].
    Lacour B; Desandes E; Mallol N; Sommelet D
    Arch Pediatr; 2005 Nov; 12(11):1577-86. PubMed ID: 16099145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphomas and leukemias in population-related cancer registries in Germany].
    Lehnert M; Baumgardt-Elms C; Stegmaier C; Liese A; Krieg V; Mattauch V; Hense HW
    Gesundheitswesen; 1999 Apr; 61(4):161-7. PubMed ID: 10408142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.
    Pollock AM; Benster R; Vickers N
    J Public Health Med; 1995 Dec; 17(4):419-28. PubMed ID: 8639341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing.
    Oberaigner W; Horninger W; Klocker H; Schönitzer D; Stühlinger W; Bartsch G
    Am J Epidemiol; 2006 Aug; 164(4):376-84. PubMed ID: 16829552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Errors in survival rates caused by routinely used deterministic record linkage methods.
    Oberaigner W
    Methods Inf Med; 2007; 46(4):420-4. PubMed ID: 17694235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
    Tracey E; Roder D; Luke C; Bishop J
    BJU Int; 2009 Aug; 104(4):498-504. PubMed ID: 19338538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.